# Innovent Biologics

> Chinese Biopharmaceutical Company.

**Wikidata**: [Q106004358](https://www.wikidata.org/wiki/Q106004358)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/Innovent_Biologics)  
**Source**: https://4ort.xyz/entity/innovent-biologics

## Summary

Innovent Biologics is a Chinese biopharmaceutical company founded on April 28, 2011, and headquartered in Suzhou, People's Republic of China. The company operates as a publicly traded entity on the Hong Kong Stock Exchange under ticker symbol 1801, and maintains a global digital presence through its official website at https://www.innoventbio.com.

## Key Facts

- **Founded**: April 28, 2011
- **Headquarters**: Suzhou, People's Republic of China
- **Legal Structure**: Public company and business entity
- **Stock Exchange**: Hong Kong Stock Exchange (ticker: 1801)
- **Official Website**: https://www.innoventbio.com
- **Legal Entity Identifier (LEI)**: 25490058ONL9SCIE1R22
- **Google Knowledge Graph ID**: /g/11f016c8rn
- **Crunchbase Organization ID**: innovent-biologics
- **Registered Aliases**: Innovent Biologics (Suzhou) Co. Ltd., Innovent, Innovent Biologics, Inc., 信达生物制药, 信达生物制药集团
- **Wikipedia Presence**: Available in English and Chinese languages with 3 total sitelinks
- **Visual Documentation**: Gate 1 of Innovent Biologics photographed on November 17, 2022, available on Wikimedia Commons

## FAQs

**What is Innovent Biologics?**
Innovent Biologics is a Chinese biopharmaceutical company established in 2011, operating as a publicly traded business on the Hong Kong Stock Exchange under the ticker 1801.

**When was Innovent Biologics founded and where is it based?**
The company was founded on April 28, 2011, and maintains its headquarters in Suzhou, People's Republic of China.

**Is Innovent Biologics publicly traded?**
Yes, Innovent Biologics is a public company listed on the Hong Kong Stock Exchange with the stock code 1801, allowing public investment in the biopharmaceutical firm.

**What other names does Innovent Biologics use?**
The organization operates under several names including Innovent Biologics (Suzhou) Co. Ltd., the shortened "Innovent," Innovent Biologics, Inc., and Chinese equivalents 信达生物制药 and 信达生物制药集团.

**How can I find verified information about Innovent Biologics?**
Official information is available through the company's website at https://www.innoventbio.com, while verified third-party data appears on Crunchbase, Wikidata, and the Google Knowledge Graph under ID /g/11f016c8rn.

## Why It Matters

Innovent Biologics represents China's growing presence in the global biopharmaceutical sector, demonstrating how domestic Chinese companies can access international capital markets through listings on major exchanges like Hong Kong. As a publicly traded entity established in 2011, the company operates under stringent disclosure requirements that provide transparency to global investors interested in China's pharmaceutical innovation landscape. Its dual-language Wikipedia presence and multiple international identifiers (LEI, Google Knowledge Graph, Crunchbase) indicate a deliberate strategy to maintain visibility across both Chinese and Western business intelligence platforms. The company's Suzhou headquarters positions it within one of China's key biotechnology hubs, contributing to regional economic development and the advancement of pharmaceutical research and manufacturing capabilities in the Yangtze River Delta region.

## Notable For

- Being a Chinese biopharmaceutical company that successfully completed a public listing on the Hong Kong Stock Exchange with ticker symbol 1801
- Maintaining five distinct legal and brand identities across both English and Chinese languages, including a Suzhou-specific corporate designation
- Establishing a comprehensive digital footprint with presence on both English and Chinese Wikipedia editions plus Wikimedia Commons imagery
- Possessing a formal Legal Entity Identifier (LEI), a standardized international code typically associated with companies engaged in global financial transactions
- Registration in Crunchbase's database, indicating recognition within the global startup and venture capital ecosystem despite being a publicly traded entity

## Body

### Company Identity and Brand Architecture

Innovent Biologics operates under a sophisticated multi-layered identity structure that bridges Chinese and international business conventions. The full legal designation "Innovent Biologics (Suzhou) Co. Ltd." anchors the corporate entity to its geographic origin, while "Innovent Biologics, Inc." provides a globally recognizable format. Chinese market operations use 信达生物制药 and the expanded 信达生物制药集团, reflecting local naming conventions for pharmaceutical enterprises. The abbreviated "Innovent" serves as the market-facing brand name.

### Corporate Structure and Public Market Status

The organization is formally classified as both a public company and a general business entity, distinguishing it from private or state-owned enterprises. This legal form enables the company to offer securities to the general public and subjects it to regulatory oversight by Hong Kong Stock Exchange authorities. The public company designation appears in Wikidata with reference to source Q55259097, last verified on September 17, 2024.

### Foundation and Geographic Presence

Innovent Biologics began operations on April 28, 2011, positioning it among a newer generation of Chinese biotechnology firms established in the 2010s. The Suzhou headquarters places the company in a city known for its advanced manufacturing sector and government support for high-tech industries. This location data is verified through Crunchbase, which tracks corporate registration information.

### Capital Markets and Trading Information

The company's securities trade exclusively on the Hong Kong Stock Exchange, one of Asia's premier financial markets. The ticker symbol 1801 serves as its unique identifier for all trading and settlement activities. This listing provides access to international institutional and retail investors seeking exposure to China's healthcare sector growth.

### Digital Presence and Knowledge Management

Innovent Biologics maintains a curated digital ecosystem across multiple platforms. The official website https://www.innoventbio.com functions as the primary corporate communications channel. Wikipedia coverage extends across both English and Chinese language editions, with three total sitelinks connecting to related topics. Visual assets are catalogued under the "Innovent Biologics" Commons category on Wikimedia, including a November 2022 photograph of Gate 1 at the company's facility.

### International Identification Framework

The company holds a Legal Entity Identifier (LEI) code 25490058ONL9SCIE1R22, a 20-character alphanumeric identifier conforming to ISO 17442 standards for legal entities participating in financial transactions. The Google Knowledge Graph identifier /g/11f016c8rn enables integration with Google's semantic search and knowledge panels. Crunchbase lists the organization under the unique identifier "innovent-biologics," connecting it to investment history, funding rounds, and industry classification data. These identifiers collectively position Innovent Biologics within global business intelligence and regulatory reporting systems.

## References

1. [Crunchbase](http://www.crunchbase.com/organization/innovent-biologics)
2. Global LEI Index